SBIR/STTR Research Award
SBIR Phase I: Label Free Nucleic Acid Assays for POC Diagnostics
Award amount
$99,745Program and phase
SBIR · Phase IAward year
2009Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- PHOENIX BIOSYSTEM, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NXDUD4NDDQ93
- Solicitation number
- NSF 08-548
- Topic code
- BC
Research abstract
This Small Business Innovation Research (SBIR) Phase I project proposes to develop a Label Free Nucleic Acid Assay for Point-Of-Care (POC) Diagnostics especially for Sexually Transmitted Infections (STI). The broader impacts of this research are to enable effective diagnosis and treatment of chlamydia and gonorrhoeae in a single visit at the clinic and thus avoid patients who currently go untreated because they are lost-to-follow-ups. The ability to obtain easily available POC tests in primary care clinics, school clinics, Emergency Department settings, or even at-home testing (OTC), may have a far reaching impact on the rates of STIs in this country.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- HPV POINT OF CARE MOLECULAR DIAGNOSTICS FOR LMICS
- RAPID POINT OF CARE MOLECULAR DIAGNOSTICS FOR HCV
- Low cost, automated smartphone based assay for semen analysis
- Rapid Nucleic Acid Test for Chlamydia in Resource Limited Settings
- POINT OF CARE HIV COMBO ASSAY
Research funding history
27 SBIR/STTR records share this UEI (2002–2022). Reported award amounts total $7,473,973. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, Department of Energy